Wave Life Sciences
92 hedge funds and large institutions have $1.19B invested in Wave Life Sciences in 2018 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 25 increasing their positions, 27 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
7% less repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 27
2.86% less ownership
Funds ownership: 84.04% → 81.18% (-2.9%)
Holders
92
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$12.4M | |
| 2 | +$8.82M | |
| 3 | +$4.32M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$2.5M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.6M |
Top Sellers
| 1 | -$18.4M | |
| 2 | -$13.9M | |
| 3 | -$7.8M | |
| 4 |
BM
Bridger Management
New York
|
-$7.33M |
| 5 |
DM
Deerfield Management
New York
|
-$6.84M |